Centers | ||
|
|
|
BLAVATNIK CENTER for Drug Discovery | Therapeutic Accelerator Program (TAP) | VMCC, University of Michigan |
The BLAVATNIK CENTER for Drug Discovery (BCDD) is a fully integrated center for translational research, based at Tel Aviv University, that comprises medicinal chemistry, biological target identification and computer-assisted drug design units under... Read more |
Test |
The VMCC is an on-campus core facility for the design and synthesis of drug-like molecules and diagnostic probes used in biomedical investigations. Our Mission: To assist biomedical researchers in translating novel therapeutic hypotheses into... |
Partnerships |
Events |
Jobs |
Johnson & Johnson to Support Pain Research at Queensland UniversityJohnson & Johnson and Institute for Molecular Bioscience (IMB) at University of Queensland have entered into research agreement to develop peptides using IMB's novel assay to treat chronic pain. Johnson & Johnson and its affiliates will provide... View all Elan and University of Cambridge Establish New Innovation CenterUniversity of Cambridge and Elan jointly established Cambridge - Elan Centre for Research Innovation and Drug Discovery. The new center will be based out of Cambridge and will focus primarily in developing innovative therapies to treat Alzheimer's... View all GSK and MD Anderson to co-develop new cancer therapeuticsGlaxoSmithkline and MD Anderson Cancer Center entered into a co-development and license agreement to develop antibody based therapeutics to treat cancer. Under this agreement MD Anderson grants exclusive rights to antibodies developed during the... View all |
No EVENTS for listing |
No Job Posts |
